Aethlon Medical Inc (AEMD) Actualités

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies

Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies PR Newswire SAN DIEGO, June 3, 2024 Phase 1 Clinical...

Form 8-K - Current report

Form 8-K - Current report

Form EFFECT - Notice of Effectiveness

Form 424B4 - Prospectus [Rule 424(b)(4)]

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Aethlon Medical Announces Pricing of $4.7 Million Public Offering

Aethlon Medical Announces Pricing of $4.7 Million Public Offering PR Newswire SAN DIEGO, May 15, 2024 SAN DIEGO, May 15, 2024 /PRNewswire/...

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]

Form 8-K - Current report

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer...

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices PR Newswire SAN DIEGO...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report